Show
Sort by
-
Non-tumour-specific PSMA-targeted radionuclide therapy enhances immune checkpoint inhibition in a syngeneic oral cancer model
-
Evaluation of [111In]FAPI-46 via dual-isotope SPECT imaging as a predictive radioligand for [177Lu]FAPI-46 biodistribution and dosimetry in mice
-
- Conference Paper
- C3
- open access
Fractionated versus single-dose PSMA-targeted radioligand therapy as adjuvant therapy in a murine model for oral squamous cell carcinoma treated with immune checkpoint inhibitors
-
- Conference Paper
- C3
- open access
Prostate-specific membrane antigen-targeted radionuclide therapy as adjunct to Immune checkpoint Inhibition in an immunocompetent murine model for oral squamous cell carcinoma
-
- Journal Article
- A2
- open access
The development of 177Lu-DOTA-CC-PSMA following a unified “Click Chemistry” protocol of synthesizing metal nuclide-conjugated radiopharmaceuticals
-
Prostate-specific membrane antigen-targeted radionuclide therapy as a novel therapeutic approach in a syngeneic immunocompetent murine model for oral squamous cell carcinoma
-
- Conference Paper
- C3
- open access
Prostate-specific membrane antigen as a potential theranostic target in a syngeneic immunocompetent murine model for oral squamous cell carcinoma
-
Dual-modality hafnium oxide nanocrystals for in vivo computed tomography and fluorescence imaging of sentinel lymph nodes
-
CO2-driven nebulization of pH-sensitive supramolecular polymers for intraperitoneal hydrogel formation and the treatment of peritoneal metastasis
-
- Journal Article
- A1
- open access
DC vaccines loaded with glioma cells killed by photodynamic therapy induce Th17 anti-tumor immunity and provide a four-gene signature for glioma prognosis